U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2493124931Intranasal Oxytocin Administration and the Neural Correlates of Social and Non-Social Visual PerceptionActive, not recruitingNo Results AvailableSocial PerceptionDrug: Oxytocin|Other: Placebohttps://ClinicalTrials.gov/show/NCT02238379
2493224932Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate CancerRecruitingNo Results AvailableProstate CancerDrug: triptorelinhttps://ClinicalTrials.gov/show/NCT02238366
2493324933AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)RecruitingNo Results AvailableAllergic Rhinitis|House Dust Mite AllergyDrug: azelastine + fluticasone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02238353
2493424934Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic SurgeryCompletedNo Results AvailableSurgeryDrug: Extended-release oxycodone|Drug: Extended- release Oxycodone|Drug: ketoprofen|Drug: dipirone|Drug: dexametasone|Drug: Morphine IV (rescue)https://ClinicalTrials.gov/show/NCT02238340
2493524935Longitudinal Evaluation of HIV-associated Lung Disease PhenotypesRecruitingNo Results AvailableChronic Obstructive Pulmonary Disease|HIV|EmphysemaProcedure: blood draw|Procedure: questionnaires|Procedure: Lung function testing|Procedure: Six-Minute walk test|Radiation: Quantitative CT scans|Procedure: Nasal secretion and cell collection|Procedure: Echocardiogram|Procedure: Glycocalyxhttps://ClinicalTrials.gov/show/NCT02238327
2493624936Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV PatientsCompletedNo Results AvailableHIV InfectionsDrug: Tipranavir low dose|Drug: Tipranavir high dose|Drug: Ritonavir|Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI)|Drug: Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)https://ClinicalTrials.gov/show/NCT02238314
2493724937Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant WomenRecruitingNo Results AvailableIntrauterine Growth RestrictionOther: Bold sequence patients test|Other: Bold sequencehttps://ClinicalTrials.gov/show/NCT02238301
2493824938Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants PatientsEnrolling by invitationNo Results AvailableOral HemorrhageDrug: Aminocaproic acid|Other: Routine dental care|Drug: lidocaine and epinephrine|Drug: Paracetamolhttps://ClinicalTrials.gov/show/NCT02238288
2493924939Post-Marketing Surveillance Study of Micardis® Plus in Patients With HypertensionCompletedNo Results AvailableHypertensionDrug: Micardis® plushttps://ClinicalTrials.gov/show/NCT02238275
2494024940Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in HospitalsCompletedNo Results AvailableHypertensionDrug: Telmisartanhttps://ClinicalTrials.gov/show/NCT02238262
2494124941Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With UrticariaCompletedNo Results AvailableUrticariaDrug: Alesion®https://ClinicalTrials.gov/show/NCT02238249
2494224942Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and PruritusCompletedNo Results AvailableRhinitis, Allergic, PerennialDrug: Alesion®https://ClinicalTrials.gov/show/NCT02238236
2494324943Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® TabletCompletedNo Results AvailableRhinitis, Allergic, PerennialDrug: Alesion®https://ClinicalTrials.gov/show/NCT02238223
2494424944Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or AllergyCompletedNo Results AvailableColdDrug: Atrovent®https://ClinicalTrials.gov/show/NCT02238210
2494524945Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Atrovent® Inhalation Solutionhttps://ClinicalTrials.gov/show/NCT02238197
2494624946Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Atrovent®|Drug: Ventilat®https://ClinicalTrials.gov/show/NCT02238184
2494724947Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Atrovent® inhaletshttps://ClinicalTrials.gov/show/NCT02238171
2494824948Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Atrovent® inhaletshttps://ClinicalTrials.gov/show/NCT02238158
2494924949Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Atrovent® Inhalettenhttps://ClinicalTrials.gov/show/NCT02238145
2495024950Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways DiseaseCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: ATROVENT® inhaletshttps://ClinicalTrials.gov/show/NCT02238132
2495124951Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium + formoterol combination|Drug: Tiotropium|Drug: Formoterolhttps://ClinicalTrials.gov/show/NCT02238119
2495224952Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Salmeterol medium dose|Drug: Salmeterol low dose|Drug: Salmeterol high dose|Drug: Serevent® Diskus®|Drug: Placebo HandiHaler®|Drug: Placebo Diskus®https://ClinicalTrials.gov/show/NCT02238106
2495324953Cardiorenal Syndrome in End-Stage Kidney DiseaseNot yet recruitingNo Results AvailableEnd-stage Renal Disease|Cardiorenal Syndrome|Heart Diseasehttps://ClinicalTrials.gov/show/NCT02238093
2495424954An Observational Study of Methoxy Polyethylene Glycol-Erythropoietin [MIRCERA] in Chronic Kidney Disease Patients on DialysisCompletedNo Results AvailableAnemiahttps://ClinicalTrials.gov/show/NCT02238080
2495524955Survey on Anemia Therapy in Patients With Chronic Kidney Disease Not on DialysisCompletedNo Results AvailableKidney Disease, Chronichttps://ClinicalTrials.gov/show/NCT02238067
2495624956French Observatory Evaluating the Use of Intracoronary Prosthesis ABSORB BVSRecruitingNo Results AvailableIntracoronary Angioplastyhttps://ClinicalTrials.gov/show/NCT02238054
2495724957GlucoClear ICU StudyNot yet recruitingNo Results AvailableIntensive Care Unit Blood Glucose MonitoringDevice: GlucoClear Systemhttps://ClinicalTrials.gov/show/NCT02238041
2495824958Intervention Study on the Health Effects of Wearing Particulate Filtering RespiratorsNot yet recruitingNo Results AvailableInflammation|Blood Pressure|Asymptomatic ConditionOther: Particulate filtering respiratorhttps://ClinicalTrials.gov/show/NCT02238028
2495924959Tear Film Evaluation After PhacoemulsificationRecruitingNo Results AvailableCortical Senile CataractProcedure: cataract surgeryhttps://ClinicalTrials.gov/show/NCT02238015
2496024960Assessment Of Anterior Chamber Configuration Changes After PhacoemulsificationRecruitingNo Results AvailableCataract|Shallow Anterior Chamber|Narrow AngleProcedure: cataract surgeryhttps://ClinicalTrials.gov/show/NCT02238002

* Görseller ve İçerik tekif hakkına sahip olabilir